Friday, September 4, 2026

Unity Bancorp, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 17, 2020

Unity Bancorp, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Seattle Genetics, Inc.

60.8% sales growth and 23.4% return on equity

Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally.

Seattle Genetics, Inc.'s sales growth this year is anticipated to be 134.9% and a negative 16.8% for next year.

Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.

Seattle Genetics, Inc.'s sales growth for the next quarter is 60.8%. The company's growth estimates for the ongoing quarter and the next is 478.6% and 72.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.4%.

Seattle Genetics, Inc.'s Stock Yearly Top and Bottom Value

Seattle Genetics, Inc.'s stock is valued at $191.18 at 16:22 EST, way below its 52-week high of $213.94 and way higher than its 52-week low of $90.57.

Seattle Genetics, Inc.'s Moving Average

Seattle Genetics, Inc.'s value is higher than its 50-day moving average of $177.10 and way above its 200-day moving average of $172.42.

2. Pinnacle Financial Partners, Inc.

12.4% sales growth and 6.55% return on equity

Pinnacle Financial Partners, Inc., together with its subsidiaries, operates as the bank holding company for Pinnacle Bank that provides various banking products and services in the United States.

Pinnacle Financial Partners, Inc.'s sales growth this year is expected to be 12.4% and 1.6% for next year.

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 898.13M for the twelve trailing months.

Pinnacle Financial Partners, Inc.'s sales growth for the next quarter is 12.4%. The company's growth estimates for the ongoing quarter and the next is 4.7% and 232.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.55%.

Pinnacle Financial Partners, Inc.'s Stock Yearly Top and Bottom Value

Pinnacle Financial Partners, Inc.'s stock is valued at $60.01 at 16:22 EST, below its 52-week high of $65.00 and way above its 52-week low of $27.80.

Pinnacle Financial Partners, Inc.'s Moving Average

Pinnacle Financial Partners, Inc.'s worth is way higher than its 50-day moving average of $52.72 and way above its 200-day moving average of $43.51.

3. Unity Bancorp, Inc.

13% sales growth and 13.83% return on equity

Unity Bancorp, Inc. operates as the holding company for Unity Bank that provides commercial and retail banking products and services to individuals, small and medium sized businesses, and professional communities.

Unity Bancorp, Inc.'s sales growth this year is anticipated to be 12.2% and 5.4% for next year.

Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 65.69M for the twelve trailing months.

Unity Bancorp, Inc.'s sales growth for the next quarter is 13%. The company's growth estimates for the current quarter and the next is 3.6% and 26.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.83%.

Unity Bancorp, Inc.'s Stock Yearly Top and Bottom Value

Unity Bancorp, Inc.'s stock is valued at $18.05 at 16:22 EST, way below its 52-week high of $24.15 and way higher than its 52-week low of $8.76.

Unity Bancorp, Inc.'s Moving Average

Unity Bancorp, Inc.'s worth is higher than its 50-day moving average of $16.58 and way higher than its 200-day moving average of $14.20.

4. Meritage Homes Corporation

27% sales growth and 18.39% return on equity

Meritage Homes Corporation designs and builds single-family homes in the United States.

Meritage Homes Corporation's sales growth this year is expected to be 20.4% and 22.7% for next year.

Year-on-year quarterly revenue growth grew by 20.9%, now sitting on 4.23B for the twelve trailing months.

Meritage Homes Corporation's sales growth for the next quarter is 27%. The company's growth estimates for the ongoing quarter and the next is 20.9% and 46.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.39%.

Meritage Homes Corporation's Stock Yearly Top and Bottom Value

Meritage Homes Corporation's stock is valued at $85.95 at 16:22 EST, way under its 52-week high of $117.06 and way higher than its 52-week low of $25.24.

Meritage Homes Corporation's Moving Average

Meritage Homes Corporation's value is below its 50-day moving average of $90.62 and below its 200-day moving average of $92.05.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com